Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,071.2
6.7 (0.22%)

 

  • STI Straits Times Index
    3,071.2
    6.7 (0.22%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,548.5
    -6.8 (-0.43%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,920.8
    252.9 (1.03%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,614.0
    6.9 (0.19%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    30,500.0
    176.7 (0.58%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,133.2
    23.3 (0.38%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,452.5M
  • Value: 2,581.7M
  • Rise: 161
  • Fall: 177
  • Unch: 416

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Hatten Land0.073+0.013
ESR-REIT0.475-0.010
OUE Com Reit0.445-
Sembcorp Marine0.084+0.001
StarhillGbl Reit0.630-0.005
ARA LOGOS Log Tr0.935+0.010
GSS Energy0.077+0.005
Lippo Malls Tr0.054+0.003
Singtel2.430+0.030
CapLand IntCom T2.000-0.020

World Indices

World Indices
Name Last Change
Nasdaq 15,181.9 +20.4
HSI 24,920.8 +252.9
HSCEI 8,940.5 +134.7
Jakarta 6,133.2 +23.3
Nikkei 225 30,500.0 +176.7
SSE Comp 3,614.0 +6.9
Shanghai A 3,787.7 +7.3
Shanghai B 273.1 -1.8
KOSPI 3,140.5 +10.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

Medtecs Intl MEDTECS INTERNATIONAL CORP LTD
Quotes 10 Minutes Delayed. Updated at 17 Sep 2021 17:14
Last (SGD): 0.425 Change: -0.030 High: 0.460 Remarks: -
Change (%): -6.59 Low: 0.420
Open 0.460 Yesterday's Close 0.455
Buy Price 0.420 Sell Price 0.425
Buy Volume ('000) 132.4 Sell Volume ('000) 270.2
Cumulative Volume ('000) 6,563.1 Cumulative Value 2,851,892
Free Trial
 
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.31869 Trailing EPS (SGD) e 0.26644 NAV (SGD) b 0.4594
PE a 1.334 Trailing PE f 1.595 Price / NAV b 0.9251
Dividend (SGD) d 0.067474 Cash In Hand (SGD) g 0.1504 Issued & Paid-up Shares c 546,411,000
Dividend Yield (%) d 15.876 Price / Cash In Hand g 2.826 Treasury Shares h 3,000,000
Beta - 75 Daysi 1.312 R-Squared - 75 Days(%)i 5.29 Market Cap (M) 232.225
Beta - 500 Daysi -0.033 R-Squared - 500 Days (%)i - Enterprise Value (M) 168.489
Piotroski F Score 8 Exchange Code 546 Par Value ( USD ) 0.05000
52 Weeks Volatility (%) 62.8859 6-Month VWAP 0.899 Free Float (%) 99.4
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 24 Aug 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 24 Aug 2021.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Medtecs Intl SGX 232.225 1.334 1.595 0.9251 15.876
Industry Medical & Biotechnology SGX 1,011.451 18.761 15.994 1.4251 3.010
Medical Specialties SGX 1,424.429 9.672 2.818 3.1885 4.132
Index FTSE ST Catalist Index SGX 61.407 33.240 24.024 1.3833 1.846
Local Peer Top Glove SGX 7,967.034 13.121 2.854 3.6235 3.930
Local Peer UGHealthcare SGX 249.585 2.101 2.102 1.3094 1.262
Local Peer Yunnan Energy SGX 46.549 - - 1.4359 -
Local Peer Biolidics SGX 34.509 - - 6.5327 -
Local Peer Annica SGX 16.675 - - 5.0000 -
Global Peer DANAHER CORP NYSE 231,303.600 65.899 65.898 5.8576 0.221
Global Peer ABBOTT LABORATORIES NYSE 225,928.181 50.509 35.602 6.6843 1.199
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 220,487.744 34.586 25.650 5.9827 0.158
Global Peer MEDTRONIC PLC NYSE 176,193.445 48.861 45.376 3.4222 1.848
Global Peer INTUITIVE SURGICAL INC NASDAQ 123,037.884 116.008 75.828 11.3530 -
Global Peer STRYKER CORP NYSE 104,119.977 65.116 49.986 7.5340 0.851
Global Peer BECTON DICKINSON & CO NYSE 75,436.197 98.352 40.448 3.1259 1.230
Global Peer EDWARDS LIFESCIENCES CORP NYSE 75,229.456 91.365 51.442 14.6552 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 63,930.865 - 136.604 4.0102 -
Global Peer ALIGN TECHNOLOGY INC NASDAQ 57,543.285 32.403 82.387 17.0025 -
Other Global Peers IDEXX LABORATORIES INC (NASDAQ), DEXCOM INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), ALCON AG (NYSE), RESMED INC (NYSE), BAXTER INTERNATIONAL INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WATERS CORP (NYSE), BIO RAD LABORATORIES INC (NYSE), COOPER COS INC (NYSE), STERIS PLC (NYSE), PERKINELMER INC (NYSE), INSULET CORPORATION (NASDAQ), HOLOGIC INC (NASDAQ), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), ABIOMED INC (NASDAQ), MASIMO CORPORATION (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), NOVOCURE LTD (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), BRUKER CORPORATION (NASDAQ), QIAGEN NV (NYSE), COCHLEAR LTD (ASX), MICROPORT (HKEx), PENUMBRA INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), SHOCKWAVE MEDICAL INC (NASDAQ), WEIGAO GROUP (HKEx), TANDEM DIABETES CARE INC (NASDAQ), ANGELALIGN (HKEx), SOTERA HEALTH CO (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), STAAR SURGICAL CO (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), TOPGLOV (Bursa), QUIDEL CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), INMODE LTD (NASDAQ), HARTA (Bursa), ICU MEDICAL INC (NASDAQ), NEOGEN CORP (NASDAQ), LIVANOVA PLC (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), NEVRO CORP (NYSE), EBOS GROUP (ASX), MERIT MEDICAL SYSTEMS (NASDAQ), INARI MEDICAL INC (NASDAQ), CONMED CORP (NYSE), CYTEK BIOSCIENCES INC (NASDAQ), CAREDX INC (NASDAQ), HAEMONETICS CORP (NYSE), ATRICURE INC (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), AXONICS INC (NASDAQ), NUVASIVE INC (NASDAQ), HESKA CORP (NASDAQ), OUTSET MEDICAL INC (NASDAQ), VENUS MEDTECH-B (HKEx), CELLDEX THERAPEUTICS INC (NASDAQ), GLAUKOS CORPORATION (NYSE), VERICEL CORP (NASDAQ), LIFETECH SCI (HKEx), BUTTERFLY NETWORK INC (NYSE), CARDIOFLOW-B (HKEx), SILK ROAD MEDICAL INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), PEIJIA-B (HKEx), IRHYTHM TECHNOLOGIES INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), ZYLOXTB-B (HKEx), KANGJI MEDICAL (HKEx), SUPERMX (Bursa), INOVIO PHARMACEUTICALS INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), AVANOS MEDICAL INC (NYSE), AK MEDICAL (HKEx), PROCEPT BIOROBOTICS CORP (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), PULMONX CORPORATION (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), NANOSONICS LIMITED (ASX), ORTHOPEDIATRICS CORP (NASDAQ), SIGHT SCIENCES INC (NASDAQ), ATRION CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), NANO-X IMAGING LTD (NASDAQ), INOGEN INC (NASDAQ), VIEWRAY INC (NASDAQ), CERUS CORP (NASDAQ), ANGIODYNAMICS INC (NASDAQ), DERMTECH INC (NASDAQ), 908 DEVICES INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), CRYOLIFE INC (NYSE), MODERN DENTAL (HKEx), CIRC (HKEx), TRANSMEDICS GROUP INC (NASDAQ), CUTERA INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), EARGO INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), SISRAM MED (HKEx), BIOVENTUS INC (NASDAQ), SURMODICS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SI BONE INC (NASDAQ), INTERCURE LTD (NASDAQ), CHUNLI MEDICAL (HKEx), NYXOAH SA (NASDAQ), VAPOTHERM INC (NYSE), KDL MEDICAL (HKEx), AXOGEN INC (NASDAQ), PAVMED INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), ANTARES PHARMA INC (NASDAQ), ACOTEC-B (HKEx), SEASPINE HOLDINGS CORP (NASDAQ), HEARTCARE-B (HKEx), FLUIDIGM CORP DEL (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), AVITA MEDICAL INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SOLITON INC (NASDAQ), METRICS INCOME OPPORTUNITIES TRUST (ASX), BASECARE-B (HKEx), MISONIX INC (NASDAQ), IRADIMED CORP (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), NEUROPACE INC (NASDAQ), ZYNEX INC (NASDAQ), STEREOTAXIS INC (NYSE American), CLEARPOINT NEURO INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), ACUTUS MEDICAL INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), SIENTRA INC (NASDAQ), ONCOCYTE CORP (NASDAQ), CONFORMIS INC (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), UTAH MEDICAL PRODUCTS (NASDAQ), CVRX INC (NASDAQ), YESTAR HEALTH (HKEx), ACCURAY INCORPORATED (NASDAQ), ICECURE MEDICAL LTD (NASDAQ), LUCIRA HEALTH INC (NASDAQ), PROFOUND MED CORP (NASDAQ), QUOTIENT LTD (NASDAQ), AROA BIOSURGERY LTD (ASX), APOLLO ENDOSURGERY INC (NASDAQ), CLARITY PHARMACEUTICALS LTD (ASX), MYMD PHARMACEUTICALS INC (NASDAQ), PW MEDTECH (HKEx), MEDICAL DEVELOPMENT INTL (ASX), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), DARIOHEALTH CORP (NASDAQ), INVACARE CORP (NYSE), SURGALIGN HOLDINGS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), INTRICOM CORP (NASDAQ), TELA BIO INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), CORMEDIX INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), NEURONETICS INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), NEMAURA MEDICAL INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), SOMNOMED LIMITED (ASX), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), CYCLOPHARM LIMITED (ASX), IMPEDIMED LIMITED (ASX), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), VENUS CONCEPT INC (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), FONAR CORP (NASDAQ), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), ALPHA PRO TECH (NYSE American), IRIDEX CORP (NASDAQ), ELECTROMED INC (NYSE American), OPTISCAN IMAGING (ASX), KELFRED (HKEx), CRYO-CELL INTERNATIONAL INC (NASDAQ), MICRO-X LTD (ASX), BIOLASE INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CHECK-CAP LTD (NASDAQ), NEPHROS INC (NASDAQ), CELSION CORPORATION (NASDAQ), SDI LTD (ASX), LENSAR INC (NASDAQ), VINCENT MED (HKEx), VOLITIONRX LIMITED (NYSE American), ZOSANO PHARMA CORP (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), AVINGER INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), SOLENO THERAPEUTICS INC (NASDAQ), IMMUCELL CORP (NASDAQ), ELECTROCORE INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), RGTBHD (Bursa), PREDICTIVE ONCOLOGY INC (NASDAQ), APPLIED UV INC (NASDAQ), NEUROMETRIX INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), SENSUS HEALTHCARE INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), YUNNAN ENERGY (HKEx), IMAGION BIOSYSTEMS LIMITED (ASX), BIOMERICA INC (NASDAQ), NEOVASC INC (NASDAQ), COMPUMEDICS (ASX), ADVENTA (Bursa), DIMERIX LTD (ASX), NANOVIBRONIX INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), DAXOR CORP (NYSE American), CARDIEX LTD (ASX), LKL (Bursa), NOVA EYE MEDICAL LIMITED (ASX), RESPIRI LTD (ASX), INSPIREMD INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), RESONANCE HEALTH LTD (ASX), TENAX THERAPEUTICS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), LBT INNOVATIONS LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), PETVIVO HLDGS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), ADHERIUM LIMITED (ASX), VIVEVE MEDICAL INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), DYNATRONICS CORP (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), RA MEDICAL SYSTEMS INC (NYSE American), XTANT MEDICAL HLDGS INC (NYSE American), OVENTUS MEDICAL LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), CYANOTECH CORP (NASDAQ), LIFE HEALTHCARE (HKEx), OSPREY MEDICAL INC NPV DFD 23/09/21(EX-SPLIT) (ASX), NUWELLIS INC (NASDAQ), METALICITY LIMITED (ASX), USCOM LTD (ASX), TRUSCREEN GROUP LTD (ASX), STAR EQUITY HOLDINGS INC (NASDAQ), HUAKANG BIOMED (HKEx), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.110
-20.56 %
10 Days --0.105
-19.81 %
20 Days --0.145
-25.44 %
Medium Term Return 3 Months --0.500
-54.05 %
6 Months 0.056-0.555
-50.92 %
1 Year 0.056-0.645
-55.05 %
Long Term Return 2 Years 0.067+0.391
+1347.06 %
3 Years 0.067+0.395
+1540.00 %
5 Years 0.067+0.377
+925.00 %
Annualised Return Annualised --
+59.27 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.
Free Trial

Price Movements

1 Year Range 0.420 - 1.590 Change From 1 Year Low +0.005 % Change From 1 Year Low (%) +1.19
Change From 1 Year High -1.165 % Change From 1 Year High (%) -73.27
2 Years Range 0.027 - 1.980 Change From 2 Years Low +0.398 % Change From 2 Years Low (%) +1474.07
Change From 2 Years High -1.555 % Change From 2 Years High (%) -78.54
5 Years Range 0.022 - 1.980 Change From 5 Years Low +0.403 % Change From 5 Years Low (%) +1831.82
Change From 5 Years High -1.555 % Change From 5 Years High (%) -78.54
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Group's business started in 1989 with the incorporation of Clement Textile & International Corporation in Philippines in 1989. Medtecs is an integrated healthcare product and services provider in Asia Pacific, and a manufacturer and distributor of medical consumables for the healthcare industry. Started in the Philippines in 1989, the Group has established its presence in the United States, Europe and the Asia Pacific region. Today, the Group has offices in Singapore, Hong Kong, Taiwan, the Philippines, Cambodia and China.The Group is an original product manufacturer (OPM) of a wide range of medical consumables for large multinational healthcare distributors, pharmaceutical companies and hospital groups in the United States and Europe. Major product groups manufactured by the Group include linen, hospital apparel, hospital apparel and bandages. The Group’s OPM is supported by 10 manufacturing facilities located in the Philippines (4), China (4) and one each in Cambodia and Taiwan.The Group also acts as agent to distribute other branded medical devices in Asia Paci8fic, including medical supplies and equipment such as wheel chairs, syringes, gauzes, digital thermometers, nebulizers, blood pressure monitors and others.The Group’s Taiwan Depository Receipts (TDR) was listed on the Taiwan Stock Exchange on 13 December 2002.The Company is an investment holding company incorporated in Bermuda on 26 November 1997.

IPO Performance

Listing Date 06 Oct 1999 Full Subscription Rate (x) 10.99
No of Placement Shares (M) 27.00 No of Public Offer Shares (M) 18.00 Public Offer Subscription Rate (x) 25.98
IPO Price (SGD) a 0.251 First Day Close (SGD) a 0.334 First Week Close (SGD) a 0.328
Current vs IPO Price (%) +69.32 First Day Gain (%) +33.07 First Week Gain (%) +30.68
Notes:
  1. Adjusted for the following: Bonus issue 1 for 5 on 29/04/2004

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2020 Dec 2020 Part 1(5.09 MB)
Annual Report 2019 Dec 2019 Part 1(5.04 MB)
Annual Report 2018 Dec 2018 Part 1(3.96 MB)
Annual Report 2017 Dec 2017 Part 1(3.57 MB)
Part 2(0.45 MB)
Annual Report 2016 Dec 2016 Part 1(2.67 MB)
Annual Report 2015 Dec 2015 Part 1(1.52 MB)
Annual Report 2014 Dec 2014 Part 1(4.00 MB)
Annual Report 2013 Dec 2013 Part 1(3.85 MB)
Annual Report 2012 Dec 2012 Part 1(3.68 MB)
Annual Report 2011 Dec 2011 Part 1(6.92 MB)
Annual Report 2010 Dec 2010 Part 1(3.56 MB)
Annual Report 2009 Dec 2009 Part 1(2.70 MB)
Annual Report 2008 Dec 2008 Part 1(1.48 MB)
Annual Report 2007 Dec 2007 Part 1(3.26 MB)
Part 2(0.02 MB)
Annual Report 2006 Dec 2006 Part 1(7.72 MB)
Annual Report 2005 Dec 2005 Part 1(23.76 MB)
IPO Prospectus
IPO Prospectus 1999 Oct 1999 Part 1(0.12 MB)
Part 2(0.39 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
17 Sep 2021 0.460 0.460 0.420 0.425 6,563,100 0.4345
16 Sep 2021 0.465 0.470 0.450 0.455 5,469,300 0.4601
15 Sep 2021 0.490 0.490 0.445 0.455 8,542,900 0.4605
14 Sep 2021 0.525 0.530 0.485 0.495 6,785,000 0.5049
13 Sep 2021 0.540 0.540 0.525 0.525 2,795,000 0.5278
10 Sep 2021 0.545 0.545 0.535 0.535 1,411,700 0.5395
09 Sep 2021 0.540 0.555 0.530 0.535 3,707,300 0.5418
08 Sep 2021 0.555 0.555 0.540 0.540 4,638,200 0.5458
07 Sep 2021 0.540 0.560 0.540 0.550 4,770,500 0.5501
06 Sep 2021 0.530 0.545 0.530 0.540 2,375,200 0.5364
03 Sep 2021 0.545 0.545 0.525 0.530 5,134,800 0.5344
02 Sep 2021 0.550 0.550 0.540 0.540 1,655,300 0.5442
01 Sep 2021 0.545 0.550 0.540 0.545 1,636,900 0.5452
31 Aug 2021 0.555 0.560 0.540 0.545 3,725,800 0.5482
30 Aug 2021 0.560 0.565 0.550 0.555 3,302,200 0.5564
27 Aug 2021 0.550 0.570 0.550 0.555 4,098,100 0.5582
26 Aug 2021 0.555 0.560 0.545 0.550 1,841,200 0.5512
25 Aug 2021 0.545 0.575 0.545 0.555 8,040,700 0.5594
24 Aug 2021 0.555 0.560 0.535 0.545 3,495,600 0.5445
23 Aug 2021 0.575 0.580 0.545 0.545 5,465,800 0.5604
20 Aug 2021 0.580 0.595 0.565 0.570 6,360,600 0.5776
19 Aug 2021 0.600 0.615 0.570 0.580 5,784,700 0.5907
Summary
Current 2 Weeks
(06 Sep 2021 to 17 Sep 2021)		 0.530 0.560 0.420 0.425 47,058,200 -
Previous 2 Weeks
(23 Aug 2021 to 03 Sep 2021)		 0.575 0.580 0.420 0.530 38,396,400 -
4 Weeks from
(23 Jul 2021 to 20 Aug 2021)		 0.835 0.850 0.420 0.570 116,201,800 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.